NCT06480318

Brief Summary

In this study, the effect of TENS applied to patients undergoing open colorectal surgery on bowel functions, pain and analgesia consumption amount will be evaluated.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 13, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

June 28, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2024

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 5, 2024

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 5, 2025

Completed
Last Updated

July 23, 2024

Status Verified

July 1, 2024

Enrollment Period

4 days

First QC Date

June 13, 2024

Last Update Submit

July 22, 2024

Conditions

Keywords

Colorectal SurgeryPain assessmentTENSNurse

Outcome Measures

Primary Outcomes (1)

  • Primary Outcome Measure

    The patient will be monitored until the 48th hour after surgery. 11th and 12th in the standard care and TENS group; 23rd and 24th; Pain assessment will be made with a numerical pain scale a total of 8 times at the 35th and 36th hours, and at the 47th and 48th hours. In the TENS group, at the 11th hour (just before TENS), at the 12th hour (1 hour after TENS), At the 23rd hour (just before TENS), at the 24th hour (1 hour after TENS), At 35th hour (just before TENS), at 36th hour (1 hour after TENS), Pain will be re-evaluated at the 47th hour (just before TENS) and at the 48th hour (1 hour after TENS). Intestinal functions of both groups will be questioned and recorded during each procedure. TENS will not be applied to the standard care group. In the TENS group, 11.,-23.,-35.,-47. TENS will be applied a total of 4 times for 20 minutes between hours. Patients' pain is expected to score at most 2-3 on a scale of 0-10.

    48 hours

Study Arms (2)

Standart Care

NO INTERVENTION

Application in the Preoperative Period: Before the surgery, HTBF and SAS will be applied to both groups and pain assessment will be made once. In addition, the intestinal functions of both groups will be questioned and recorded during each procedure. TENS will not be applied to the control group, and to the TENS group, 11.,-23.,-35.,-47. TENS will be applied a total of 4 times for 20 minutes between hours. There will be no intervention in the routine analgesic application of the clinic for both groups.

TENS (Transcutaneous electrical nerve stimulation)

EXPERIMENTAL

In the postoperative period, an information form regarding the surgery will be filled out in both groups. In addition, 11th and 12th in the control and TENS groups; 23rd and 24th; Pain assessment will be made with PSA a total of 8 times at the 35th and 36th hours, and at the 47th and 48th hours. In the TENS group, at the 11th hour (just before TENS), at the 12th hour (1 hour after TENS), at the 23rd hour (just before TENS), at the 24th hour (1 hour after TENS), at the 35th hour. Pain will be re-evaluated at 30 hours (just before TENS), 36 hours (1 hour after TENS), 47 hours (just before TENS), 48 hours (1 hour after TENS).

Device: TENS

Interventions

TENSDEVICE

The device is portable and battery-powered to preserve the patient functional activity. The device has two channels and the parameters of each channel can be adjusted independently of the other. The device contains a power supply, amplifier and electrodes to give a warning. The power supply and amplifier are located within the TENS device. Electrodes are connected to the device via cables. The current produced in the power supply is increased in the amplifier and reaches the electrodes. The device is self-gel to facilitate the transmission of current between the electrodes made of carbon silicon alloy and the skin surface. In the research, a dual-channel, four-electrode (5 cm x 5cm) TENS device will be used. TENS application will be applied every 12 hours, twice and for 20 minutes, 24 hours after the surgery.

TENS (Transcutaneous electrical nerve stimulation)

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility Details18 years and over
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Those over 18 years of age,
  • Able to communicate verbally,
  • Those who have undergone colorectal open surgery,
  • American Society of Anesthesiology (ASA) evaluation I, II, III,
  • As a result of evaluation by the physician, there is no harm in applying TENS,
  • Patients who agreed to participate in the study voluntarily were included in the sample group.

You may not qualify if:

  • In need of mechanical ventilation,
  • Having an infected wound in the surgery area,
  • Having undergone rectal surgery,
  • Using opioids before surgery,
  • Previous history of chronic pain, alcohol or drug addiction,
  • Those with cognitive and mental disabilities,
  • Those with a pacemaker and arrhythmia,
  • Epidural analgesia/patient-controlled analgesia was applied in the postoperative period,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Transcutaneous Electric Nerve Stimulation

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsPhysical Therapy ModalitiesRehabilitationAnalgesiaAnesthesia and Analgesia

Study Officials

  • sevilay erden, Phd

    Cukurova Universty

    STUDY DIRECTOR

Central Study Contacts

ilknur tura, MsC

CONTACT

sevilay erden, Phd

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Research Assistant

Study Record Dates

First Submitted

June 13, 2024

First Posted

June 28, 2024

Study Start

September 1, 2024

Primary Completion

September 5, 2024

Study Completion

July 5, 2025

Last Updated

July 23, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Hospital approval is awaited for the study, and after approval, the data collection phase will begin.